Gustavo A Ruiz Buendía

5PUBLICATIONS
50CO-AUTHORS
Innate immunityMedical infection agents (incl. prions)Molecular targetsHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 26, 2026
Baseline interferon signaling in monocytes and antibody-mediated innate activation are associated with reactogenicity to mRNA vaccines.

|Nov 30, 2024
Features of chronic urticaria after COVID-19 mRNA vaccine over time.

Johan Schwab, Mathilde Foglierini, Eva Pescosolido

|Jun 26, 2023
Resistance mechanism to Notch inhibition and combination therapy in human T-cell acute lymphoblastic leukemia.

Linlin Cao, Gustavo A Ruiz Buendía, Nadine Fournier

|Jan 12, 2022
Tcf1 is essential for initiation of oncogenic Notch1-driven chromatin topology in T-ALL.

Mateusz Antoszewski, Nadine Fournier, Gustavo A Ruiz Buendía

|Jul 14, 2020
Three-dimensional chromatin interactions remain stable upon CAG/CTG repeat expansion.

Gustavo A Ruiz Buendía, Marion Leleu, Flavia Marzetta

Pageof 1

Frequent Collaborators

2 joint publications

Arnaud M Didierlaurent

2 joint publications

Freddy Radtke

2 joint publications

Yuanlong Liu

2 joint publications

Nadine Fournier